{
  "catalogId": "179cd801-3e7f-47d0-a561-dfafc74f5704",
  "name": "TRIXEO AEROSPHERE",
  "status": "draft",
  "category": "prescription",
  "registrationValidity": "valid",
  "registrationNumber": "169 60 36905 99",
  "treatmentDescriptions": "Trixeo Aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (COPD) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist",
  "termsOfIssue": "Prescription required",
  "form": "suspension for inhalation",
  "route": "inhalation",
  "site": "",
  "method": "",
  "administrationNotes": "",
  "ingredients": "FORMOTEROL FUMARATE DIHYDRATE, GLYCOPYRRONIUM 7.2  MCG, BUDESONIDE",
  "codes": {
    "atc5": {
      "system": "WHO ATC Classification",
      "code": "R03BA02",
      "name": "BUDESONIDE"
    }
  },
  "contraindications": "",
  "sideEffect": "",
  "warnings": "תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת",
  "alternativeMedications": [],
  "packaging": [
    {
      "name": "TRIXEO AEROSPHERE 5/7.2/160 MCG 120 DOSES",
      "manufacturer": {
        "name": "אסטראזנקה",
        "countryOfOrigin": "IL"
      },
      "strength": {
        "value": 0,
        "unit": ""
      },
      "quantity": {
        "value": 120.0,
        "unit": "units"
      },
      "packagingDescription": "METERED DOSE INHALER ALUMINIUM",
      "shelfLife": "36",
      "storageConditions": "",
      "codes": {
        "moh": "9009",
        "yarpa": "76804",
        "pharmasoft": "17614"
      },
      "manufacturersAdministrationRecommendation": "",
      "pricing": {
        "currency": "ILS",
        "maxWholesalePrice": 202.580892,
        "retailMargin": 17.5,
        "maxRetailPrice": 238.0325481,
        "maxPriceWithVAT": 280.8783943
      }
    }
  ],
  "metadata": {
    "version": "1.4",
    "lastUpdated": "2025-08-01T12:18:43.044222"
  }
}